Bayer & ConcertAI Team Up, Tempus AI Secures $200M, and Yale & Google Launch Cell2Sentence-Scale - Life AI Weekly #15

Hi there, In this edition of Life AI Weekly, we're diving into the latest advancements in AI within the healthcare and life sciences sectors. Bayer has teamed up with ConcertAI to enhance precision oncology, aiming to improve cancer treatment outcomes. Meanwhile, Precision for Medicine and PathAI are collaborating to bring AI-driven services to clinical trials, potentially speeding up the development of new therapies. Johnson & Johnson is refocusing its AI strategy to concentrate on high-value use cases, ensuring that their AI initiatives deliver significant impact. On the financial front, Tempus AI has secured $200 million to further develop its cancer model, while Araceli Biosciences raised $11.2 million for AI drug discovery. In healthcare technology, Axtria launched a new AI platform for life sciences, and SimonMed Imaging partnered with Lunit to enhance breast cancer detection using AI. These developments highlight the growing integration of AI in healthcare, promising to transform patient care and medical research.

Harbinger Health has appointed Matt Turner as President and Hutan Ashrafian as Chief Medical Officer, while expanding its Board of Directors with Ajit Singh. Tempus AI has partnered with AstraZeneca and Pathos AI to develop a data-driven oncology model, securing $200 million for data licensing and model development. Araceli Biosciences has raised $11.2 million in Seed funding to enhance its AI-driven drug discovery efforts, focusing on high-content imaging and real-time analysis.

Bayer has signed a multiyear agreement with ConcertAI to advance its precision oncology efforts. Precision for Medicine and PathAI announced a strategic partnership to develop AI technologies for clinical trials. Johnson & Johnson is refocusing its AI strategy on high-value applications like drug discovery. O'Shaughnessy Ventures LLC awarded a $100,000 fellowship to AI researcher Miguel Solano. Unravel Biosciences seeks approval for clinical studies in Colombia for RVL-001.

Yale University and Google Research have introduced Cell2Sentence-Scale, a new open-source language model. This tool is designed to translate complex cellular data into understandable language for researchers. Researchers from Google Research and Yale University have introduced C2S-Scale, a set of open-source models to interpret single-cell RNA sequencing data. HKUMed has developed the world's first AI model for diagnosing thyroid cancer, boasting over 90% accuracy and reducing consultation preparation time.

Axtria has introduced Axtria InsightsMAx.ai, an AI platform aimed at helping life sciences companies innovate by deploying, scaling, and monetizing AI solutions. SimonMed Imaging has partnered with Lunit to enhance AI technology for breast cancer detection. The Advanced Medical Technology Association and the Medical Device Manufacturers Association are requesting changes to the FDA's draft guidance on AI-enabled medical devices.